Published in Cancer Weekly, July 20th, 2004
Pain Therapeutics executives said June 29, 2004, that a 10-person experiment conducted in the United Kingdom showed that its gel capsule, called Remoxy, resisted abuse better than the pill OxyContin.
OxyContin is the most popular form of the narcotic oxycodone and accounts for about $1.7 billion in annual sales, according to manufacturer Purdue Pharmaceuticals, a privately held company in Stamford, Connecticut. Doctors widely prescribe the time-release pill as an effective way to dull...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.